Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baermed Solutions is the commercial and clinical development arm of the Baermed Group, a Swiss center of excellence for abdominal medicine and regenerative therapies. The company specializes in the development of biomedical mini-organs and cell matrix implants, primarily focusing on the HEPADUA® Mini-Liver Implant for patients with chronic liver disease and cirrhosis. This technology utilizes a patented matrix carrier seeded with autologous liver and pancreas cells to restore organ function. Baermed also develops specialized matrices for anti-adhesion and hernia repair. The group integrates basic research conducted at its laboratory in Jakarta, Indonesia, with clinical practice and development based in Zurich, Switzerland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baermed Solutions.